Plus Therapeutics, Inc.
Overview
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. Their proprietary platform seeks to deliver improved outcomes through the precise delivery of radiation to tumors.
Core services & business areas
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Plus Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Plus Therapeutics, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.